approval
saveBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
September 26, 2023updated 5mo ago
community read0 votes
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalSep 26, 2023
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalOct 3, 2023
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalOct 3, 2023
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalOct 3, 2023
- approvalEfudex: FLUOROURACIL — FDA approvalOct 18, 2023
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalAug 25, 2023
🐶 often sniffed alongside
top 8- tagRecall15 co-mentions · 5 sources
- drugElyxyb6 co-mentions · 1 sources
- drugCELECOXIB6 co-mentions · 1 sources
- drugcelecoxib SR6 co-mentions · 1 sources
- drugCelebrex6 co-mentions · 1 sources
- drugfesoterodine fumarate ER6 co-mentions · 2 sources
- drugtadalafil3 co-mentions · 1 sources
- drugdoxepin hydrochloride3 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that